The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Mitchell Machtay

Department of Radiation Oncology

University of Pennsylvania

Philadelphia 19104

USA

[email]@xrt.upenn.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Radiation Oncology, University of Pennsylvania, Philadelphia 19104, USA. 1999 - 2004
  • University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA. 2003

References

  1. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay, M., Lee, J.H., Stevenson, J.P., Shrager, J.B., Algazy, K.M., Treat, J., Kaiser, L.R. J. Thorac. Cardiovasc. Surg. (2004) [Pubmed]
  2. Complex and controversial issues in locally advanced non-small cell lung carcinoma. Machtay, M., Jeremic, B. Semin. Surg. Oncol (2003) [Pubmed]
  3. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial. Machtay, M., Rosenthal, D.I., Hershock, D., Jones, H., Williamson, S., Greenberg, M.J., Weinstein, G.S., Aviles, V.M., Chalian, A.A., Weber, R.S. J. Clin. Oncol. (2002) [Pubmed]
  4. Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. Machtay, M., Lee, J.H., Shrager, J.B., Kaiser, L.R., Glatstein, E. J. Clin. Oncol. (2001) [Pubmed]
  5. A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer. Machtay, M., Aviles, V., Kligerman, M.M., Treat, J., Weinstein, G.S., Weber, R.S., Mirza, N., Chalian, A.A., Rosenthal, D.I. Int. J. Radiat. Oncol. Biol. Phys. (1999) [Pubmed]
 
WikiGenes - Universities